Literature DB >> 3924452

Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?

J C Gluckman, D Klatzmann, M Cavaille-Coll, E Brisson, A Messiah, D Lachiver, W Rozenbaum.   

Abstract

We have investigated the respective role of quantitative T lymphocyte subset abnormalities, interleukin-2 (IL-2) production and responsiveness to IL-2, in the proliferative deficiency that is observed in acquired immune deficiency syndrome (AIDS) and Lymphadenopathy syndrome (LAS) patients or even in some apparently healthy male homosexuals. 83 subjects were evaluated: 35 symptom free male homosexuals (HC), 24 LAS and 24 AIDS patients. As expected, many HC and most patients presented with T lymphocyte subset imbalance. These quantitative defects were associated with decreased reactivity to PHA and reduced production of IL-2 by PHA stimulated lymphocytes. No correlation however could be found between these two functions and variations in the T lymphocyte subset distribution. On the other hand, PHA responsiveness appeared to closely depend on IL-2 activity. Addition of exogenous IL-2 to lymphocytes from patients with low proliferative responses, stimulated with suboptimal PHA concentration, enhanced proliferation in some but not all the cases. In most instances this increase never reached the levels observed with similarly treated cells from normal individuals. In these patients, the limited number of lymphocytes which express IL-2 receptors upon PHA stimulation may explain both low PHA reactivity and reduced IL-2 responsiveness. These data indicate some possible mechanisms of immunodeficiency in AIDS and LAS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924452      PMCID: PMC1577012     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Studies of cellular immunity in male homosexuals in London.

Authors:  A J Pinching; T J McManus; D J Jeffries; O Moshtael; M Donaghy; J M Parkin; P E Munday; J R Harris
Journal:  Lancet       Date:  1983-07-16       Impact factor: 79.321

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  T-lymphocyte subpopulations in homosexual men.

Authors:  H Kornfeld; R A Vande Stouwe; M Lange; M M Reddy; M H Grieco
Journal:  N Engl J Med       Date:  1982-09-16       Impact factor: 91.245

4.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

5.  The mechanism of inhibition of human IL 2 production.

Authors:  S Chouaib; D Fradelizi
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

6.  Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

Authors:  J Laurence; A B Gottlieb; H G Kunkel
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

7.  Acquired immune dysfunction in homosexual men: immunologic profiles.

Authors:  A J Ammann; D Abrams; M Conant; D Chudwin; M Cowan; P Volberding; B Lewis; C Casavant
Journal:  Clin Immunol Immunopathol       Date:  1983-06

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  The mechanism of retrovirus suppression of human T cell proliferation in vitro.

Authors:  E A Copelan; J J Rinehart; M Lewis; L Mathes; R Olsen; A Sagone
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

10.  Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes.

Authors:  S C Meuer; R E Hussey; A C Penta; K A Fitzgerald; B M Stadler; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

View more
  9 in total

1.  CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual.

Authors:  C E Mackewicz; H W Ortega; J A Levy
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

2.  Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus.

Authors:  J Bentin; C D Tsoukas; J A McCutchan; S A Spector; D D Richman; J H Vaughan
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

3.  Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.

Authors:  J F Krowka; D P Stites; S Jain; K S Steimer; C George-Nascimento; A Gyenes; P J Barr; H Hollander; A R Moss; J M Homsy
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  G Lemm; H Warnatz
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

Review 5.  Cellular immunology of HIV-infection.

Authors:  G P Spickett; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

6.  Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.

Authors:  R P Donnelly; M F La Via; K Y Tsang
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

7.  Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.

Authors:  J Krowka; D Stites; J Mills; H Hollander; T McHugh; M Busch; L Wilhelm; L Blackwood
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

8.  Lymphocyte subpopulation profiles and mitogen kinetics in immunological deficiency testing.

Authors:  R M Radvany; M S Schubert; M Kiamar; V Jarzabek; K Koehler-Carone; D Kuban; F Hecht
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

9.  Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.

Authors:  H Nakashima; T Matsui; S Harada; N Kobayashi; A Matsuda; T Ueda; N Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.